Fate Therapeutics Larger Than S&P 500 Component Organon
August 02, 2021 at 16:39 PM EDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Fate Therapeutics Inc (FATE) was identified as having a larger market cap than the smaller end of the S&P 500, for example Organon & Co (OGN), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..